DSGN - Design Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

DSGN is currently covered by 2 analysts with an average price target of $20.5. This is a potential upside of $11.48 (127.27%) from yesterday's end of day stock price of $9.02.

Design Therapeutics's activity chart (see below) currently has 32 price targets and 31 ratings on display. The stock rating distribution of DSGN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 46.67% of the time, taking 260.8 days on average.

Highest price target for DSGN is $22, Lowest price target is $19, average price target is $20.5.

Most recent stock forecast was given by LEONID TIMASHEV from RBC on 05-Nov-2026. First documented stock forecast 20-Apr-2021.

Best performing analysts who are covering DSGN - Design Therapeutics:

Madhu Kumar Laura Chico Leonid Timashev Yasmeen Rahimi Joseph Schwartz

Currently out of the existing stock ratings of DSGN, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Mar-2026

$19

$9.98 (110.64%)

$20

17 days ago
(05-Nov-2026)

7/12 (58.33%)

$9.33 (96.48%)

150

Buy Since 20-Apr-2021

$22

$12.98 (143.90%)

$22

6 months 4 days ago
(18-May-2026)

0/4 (0%)

$11.3 (105.61%)

Hold Since 07-May-2024

$12

2 years 6 months 15 days ago
(07-May-2024)

1/4 (25%)

$7.31 (155.86%)

699

Hold Since 14-Nov-2023

$5

$6

3 years 8 days ago
(14-Nov-2023)

3/6 (50%)

$2.71 (118.34%)

247

Sell Since 19-Jan-2022

$6

$10

4 years 5 months 29 days ago
(24-May-2022)

2/2 (100%)

$-5.92 (-49.66%)

208

Show more analysts

Please expand the browser size to see the chart

What is DSGN (Design Therapeutics) average time for price targets to be met?

On average it took 261 days for the stock forecasts to be reached, with an average price target met ratio of 46.67%.

Which analyst most recently updated their price target on DSGN (Design Therapeutics)?

Leonid Timashev

Which analyst has the lowest performance score on DSGN (Design Therapeutics) with a proven track record?

JOSEPH SCHWARTZ

Which analyst has the most public recommendations on DSGN (Design Therapeutics)?

Leonid Timashev works at RBC and has 8 price targets and 5 ratings on DSGN

Which analyst is the currently most bullish on DSGN (Design Therapeutics)?

Joseph Schwartz with the highest potential upside of $12.98

Which analyst is the currently most reserved on DSGN (Design Therapeutics)?

Laura Chico with the lowest potential downside of -$4.02
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?